Company Profile

Cerilliant Corporation (“Cerilliant”) is a privately held Texas Corporation located in Round Rock, Texas, a suburb of Austin. Formerly known as the Analytical Reference Materials Division of Radian International (the “Division”), Cerilliant has attracted a team of scientific and quality control experts who, together, have forged a reputation for excellence that goes back more than 25 years. Cerilliant's consistent ability to produce analytical reference standards and custom chemicals of uncompromising quality has won the respect of industry scientists and the loyal following of customers in the highly demanding fields of forensics, diagnostics, environmental science, nutraceutical manufacturing, and pharmaceuticals.

Radian's parent, URS Corporation, made the decision to divest the division in 2000. Cerilliant was formed following the purchase of the division by private investors in August 2000. The company is still owned by the same small group of private investors.

Since its formation, the company has steadily grown from 23 to 62 employees and serves more than 2000 active customers, including federal and state governmental organizations and laboratories, private laboratories, hospitals, universities, pharmaceutical concerns, contract research organizations, equipment manufacturers, and industrial concerns. Today Cerilliant offers more than 4000 different products of which approximately 2000 are maintained in inventory. Cerilliant synthesizes in-house approximately 60% of the neat materials utilized in its products. In addition to offering catalog, customer specific, and private label reference standards, Cerilliant provides custom materials and services to its customer base including custom synthesis of neat reference materials; custom solution standards; custom packaging of neat or solution materials; analytical certifications; and storage, management, and distribution of customer reference standard inventory. Approximately 30% of Cerilliant's business is custom products and services. Cerilliant's products are distributed throughout the entire world. Cerilliant has a wholly-owned subsidiary, Austin Pharma, LLC, which is currently manufacturing one active pharmaceutical ingredient.

The Division began producing chemical reference standards in 1980 to address the needs of the emerging environmental testing industry and was the first to produce ¹³C labeled chlorinated Dioxins and Furans in cooperation with Cambridge Isotope Laboratories. Cerilliant was also the first to offer isotope-labeled drugs-of-abuse reference standards to the forensic drug testing industry and pioneered DEA exempt preparations of controlled substances in solution to better serve its customers. Cerilliant has grown to become a world leader in providing a wide variety of high quality reference standards and materials for the forensic testing industry, the environmental testing industry, and the pharmaceutical industry.

Cerilliant's operations are located in Round Rock, Texas in a light industrial park. Its current operations are housed in approximately 32,000 square feet of leased space, of which approximately half is dedicated to its production operations. The remainder of the space is dedicated to sales and administrative functions. Cerilliant recently leased an additional 12,000 square feet which will be built out in 2007 to expand its operations. Cerilliant's facility is fully secured with controlled access requiring all visitors to register and be escorted. Access is further limited into the production and material storage areas. The production area includes segregated suites for organic synthesis work (bench scale to multi-kg); isolation suites for synthesis of toxic, hazardous, or light sensitive materials; cGMP synthesis suites; reference standard manufacturing; ampule filling, powder filling, packaging; analytical testing; shipping; receiving; and controlled storage for bulk and finished products. Cerilliant's synthesis suites are negative pressure, controlled environments with sophisticated air handling and ventilation systems. The cGMP areas are isolated, positive pressure, controlled environments with dedicated and sophisticated air handling, ventilation, and environmental monitoring systems. Cerilliant also maintains controlled environments for the storage of DEA controlled substances (Schedule I through Schedule V). Cerilliant's facilities and procedures are well suited to the production of a variety of compounds and are designed to meet the specifications outlined in cGMP 21CFR211.

The company utilizes up-to-date, sophisticated equipment for the manufacture and testing of its products and raw materials. Raw materials and finished products are analyzed and certified in Cerilliant's in-house analytical laboratory utilizing fully qualified, state-of-the-art, instrumentation including: GC, GC-MS, HPLC, LC-MS, NMR, Karl Fisher Coulometry, FTIR, TLC, MP, and UV. Analysis by other methods may be outsourced to one of Cerilliant's approved laboratory partners. All testing equipment utilized for material and product release is qualified and regular calibrations are performed. Materials utilized in the production of Cerilliant products are tested and fully characterized before released into production. Products manufactured at Cerilliant are fully documented through the use of batch records to provide traceability of materials used, equipment utilized, and work performed. Cerilliant offers its customers a comprehensive Certificate of Analysis for every product.

Cerilliant employs 60+ highly trained and professional employees. Over 60% of its employees hold science degrees. All employees must pass extensive background checks and drug screens. All employees are subjected to rigorous and continuous training specific to their job function. Cerilliant prides itself on providing a safe working environment for its employees in compliance with applicable regulations and good practices.

Cerilliant has a strong quality system. Cerilliant's Quality Control department is independent of production and makes the ultimate determination on product certification. All data is peer reviewed prior to release from QC. All project records are then reviewed by Cerilliant's Quality Assurance department prior to final release. Cerilliant's quality system adheres to most of the guidelines of ISO 34 and cGMP. The Company is ISO 9001:2000 registered (BSI certificate number FM 36939, since 1997). Cerilliant is also registered with the DEA to manufacture and provide controlled substances and is licensed with the ATFE as a manufacturer of high explosives.